Offerings Archives - Page 159 of 166

1 minute read

This Psychedelics Company Is Setting Up An Equity Program For Up To $35M In Shares

August 9, 5:50 PM

Cybin Inc. (NEO: CYBN) (NYSE: CYBN) has launched an at-the-market (ATM) equity program through which it will issue and sell up to $35 million in common shares in the company’s capital, from the treasury to the public.

CYBN

1 minute read

Heron Shares Jump After Equity Financing, Q2 Earnings

By Vandana Singh

August 9, 2:10 PM

Heron Therapeutics Inc (NASDAQ:HRTX) reported Q2 sales of $27.63 million, +23.1% Y/Y, beating the consensus of $24.31 million. Oncology sales…

HRTX

1 minute read

Tonix Pharmaceuticals Says Raises Size Of Common Stock Offering From $240M To $320M

By Benzinga Newsdesk

August 9, 9:21 AM

-SEC Filing

TNXP

1 minute read

Medicenna Prices 3,333,334 Unit Offering At $1.50/Unit

By Bill Haddad

August 9, 9:16 AM

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (NASDAQ:MDNA, TSX:MDNA), a clinical stage immunotherapy company, announced today that it has priced its previously-announced marketedMedicenna Therapeutics Corp.

MDNA

1 minute read

Ainos Priced 780,000 Unit Public Offering @$4.25/Unit; Shares Will be Uplisted to NASDAQ; Company Effectuated a 1:15 Reverse Stock Split

By Charles Gross

August 9, 5:57 AM

Ainos, Inc.

AIMD

1 minute read

PennantPark Floating Rate Capital Ltd. Priced 4M Share Public Offering of Common Stock @$12.40/Share

By Charles Gross

August 9, 5:54 AM

PennantPark Floating Rate Capital Ltd.

PFLT

1 minute read

UPDATE: Papa John’s International Files For Offering Of Up To 2.8M Shares Of Common Stock By Selling Stockholders

By Michael Horton

August 8, 5:20 PM

-Reuters

PZZA

1 minute read

Nexgen Energy Files For $500M Mixed Shelf Offering

By Benzinga Newsdesk

August 5, 4:00 PM

-SEC Filing

NXE

2 minute read

Helius Medical Technologies, Inc. Prices 24M Share Common Stock Offering For Proceeds Of $18M

By Bill Haddad

August 5, 8:41 AM

Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the pricing of a public offering of (i) 24,000,000

HSDT

1 minute read

Quoin Pharmaceuticals Says We Are Offering On A ‘Reasonable Best Efforts’ Basis Up To $14M Of Ordinary Shares

By Benzinga Newsdesk

August 4, 11:50 AM

-SEC Filing

QNRX